Company Filing History:
Years Active: 2012
Title: Innovator of Enzymatic Debridement: Michal Be'eri-Lipperman
Introduction: Michal Be'eri-Lipperman is a notable inventor residing in Moshav Beit Heruth, Israel. With a focus on biomedical innovations, he holds a patent for an advanced apparatus designed to enhance the treatment of skin lesions through enzymatic debridement. His contributions to the field reflect the intersection of technology and healthcare.
Latest Patents: Michal Be'eri-Lipperman's key patent is titled "Apparatus and Methods for Enzymatic Debridement of Skin Lesions." This invention presents an apparatus that employs a set of height- and angle-adjustable inlet tubes alongside at least one outlet tube, designed to effectively treat devitalized tissue. This system features a member that creates an occlusive seal around the skin lesion, allowing for a continuous stream of enzymatic solution to flow into the wound bed. The outlet tube facilitates the removal of the enzymatic solution, any draining fluids, and tissue debris, ultimately enhancing the healing process.
Career Highlights: Throughout his career, Michal has been associated with prestigious organizations such as Ramot at Tel Aviv University and Enzysurge Ltd. His work in these companies has furthered his research and development skills, allowing him to focus on impactful medical innovations.
Collaborations: In his journey of innovation, Michal Be'eri-Lipperman has collaborated with talented individuals such as Amihay Freeman and Eran Hirszowicz. Their collective expertise in respective fields contributes significantly to the advancements in biomedical technologies and enhances the potential of Michal's inventions.
Conclusion: Michal Be'eri-Lipperman stands out as a dedicated inventor whose work in enzymatic debridement demonstrates his commitment to improving healthcare solutions. His patent reflects a significant advancement in the treatment of skin lesions, showcasing the critical role inventors play in developing innovative medical technologies for better patient outcomes.